Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
NCT06533527Phase 4Completed
- Sponsor
- Cleveland Clinic
- Start
- Jul 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) and obesity (2 arms), sponsored by Cleveland Clinic. Primary endpoints: Residual gastric volume that precludes adequate endoscopic examination, Residual gastric volume that necessitates premature termination of the endoscopy procedure and 2 more. Started Jul 2024; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT06533527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06533527.